Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, United States.
Biochim Biophys Acta Biomembr. 2018 May;1860(5):1046-1056. doi: 10.1016/j.bbamem.2018.01.007. Epub 2018 Jan 6.
The PKC isozymes represent the most prominent family of signaling proteins mediating response to the ubiquitous second messenger diacylglycerol. Among them, PKCθ is critically involved in T-cell activation. Whereas all the other conventional and novel PKC isoforms have twin C1 domains with potent binding activity for phorbol esters, in PKCθ only the C1b domain possesses potent binding activity, with little or no activity reported for the C1a domain. In order to better understand the structural basis accounting for the very weak ligand binding of the PKCθ C1a domain, we assessed the effect on ligand binding of twelve amino acid residues which differed between the C1a and C1b domains of PKCθ. Mutation of Pro of the C1a domain of PKCθ to the corresponding Lys found in C1b restored in vitro binding activity for [H]phorbol 12,13-dibutyrate to 3.6 nM, whereas none of the other residues had substantial effect. Interestingly, the converse mutation in the C1b domain of Lys to Pro only diminished binding affinity to 11.7 nM, compared to 254 nM in the unmutated C1a. In confocal experiments, deletion of the C1b domain from full length PKCθ diminished, whereas deletion of the C1a domain enhanced 5-fold (at 100 nM PMA) the translocation to the plasma membrane. We conclude that the Pro residue in the C1a domain of full length PKCθ plays a critical role in the ligand and membrane binding, while exchanging the residue (Lys) at the same position in C1b domain of full length PKCθ only modestly reduced the membrane interaction.
蛋白激酶 C(PKC)同工酶是介导对普遍存在的第二信使二酰基甘油反应的信号蛋白中最主要的家族。其中,PKCθ 在 T 细胞激活中起着至关重要的作用。虽然所有其他传统和新型 PKC 同工型都具有两个具有强大佛波醇酯结合活性的 C1 结构域,但在 PKCθ 中,只有 C1b 结构域具有强大的结合活性,而 C1a 结构域的结合活性很小或没有报道。为了更好地理解导致 PKCθ C1a 结构域配体结合非常弱的结构基础,我们评估了在 12 个氨基酸残基上的差异对配体结合的影响,这些残基存在于 PKCθ 的 C1a 和 C1b 结构域之间。将 PKCθ C1a 结构域中的 Pro 突变为 C1b 中对应的 Lys,恢复了 [H]佛波醇 12,13-二丁酸的体外结合活性至 3.6 nM,而其他残基则没有显著影响。有趣的是,C1b 结构域中的 Lys 突变为 Pro 仅将结合亲和力降低至 11.7 nM,而未突变的 C1a 则为 254 nM。在共聚焦实验中,从全长 PKCθ 中删除 C1b 结构域会减弱,而删除 C1a 结构域会增强 5 倍(在 100 nM PMA 下)向质膜的易位。我们得出结论,全长 PKCθ 的 C1a 结构域中的 Pro 残基在配体和膜结合中起着关键作用,而在全长 PKCθ 的 C1b 结构域中交换相同位置的残基(Lys)仅适度降低了膜相互作用。